Bioinformatic screening of Lamiaceae family compounds as potential inhibitors of spikemediated receptor-binding of SARS-CoV-۲

Publish Year: 1400
نوع سند: مقاله کنفرانسی
زبان: English
View: 193

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

IBIS10_145

تاریخ نمایه سازی: 5 تیر 1401

Abstract:

COVID-۱۹ (coronavirus disease ۲۰۱۹) still remains a major challenge worldwide. The coronavirus causesthe disease by binding to ACE۲ receptors on lung cells, infecting the cells and triggering the onset ofsymptoms. The prevention of such binding in which the virus is eventually unable to enter the cell could bea promising therapeutic approach. In this in silico study, ۳۰۶ compounds of Lamiaceae family native in Iranwere retrieved from ChEBI, PubChem, Chemspider and ZINC۱۵ serevers as ۳D structures in SDF files.Crystal structure of SARS-CoV-۲ spike RBD was obtained as bound with ACE۲ from Protein Data Bank(PDB) database (PDB ID: ۶M۰J). Then, the compounds with inhibitory potential were selected by moleculardocking and virtual screening using Autodock vina tools embedded in PyRx software, in terms of free energybinding against the spike protein of the virus. The pharmacokinetic profile of selected compounds wasevaluated using SwissADME website. Afterwards, by molecular dynamic simulation using GROMACSpackage and RMSD and RMSF analysis as well as MM/PBSA method, four compounds were furtherassessed for binding affinities against the receptor-binding domain of spike. The results showed that twocompounds, Catechin gallate and Perovskone B derived from Stachys and Salvia genus generated strongerbinding affinity against the target and thus could act as potential inhibitory compounds of RBD of the SARSCoV-۲ spike protein.

Authors

Abbas Alibakhshi

Molecular Medicine Research Center, Hamadan University of Medical Sciences, Hamadan, Iran

Shima Gharibi

Core Research Facilities (CRF), Isfahan University of Medical Sciences, Isfahan, Iran

Shahrzad Ahangarzadeh

Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Fatemeh Yarian

Department of Medical Biotechnology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran